mYXpression targets your biotherapy

mYXpression targets your biotherapy

Targeted biotherapy considerably increases the chances of achieving lasting remission (DAS28 <2.6). Thanks to RITI®, identify precisely the one that suits you.

Rheumatoid arthritis:
the aim is sustainable remission

Biotherapies have revolutionised the therapeutic care of rheumatoid arthritis. These new-generation treatments are very effective and have led to 2 conclusions:

  • icone - Biothérapie ciblée

    A targeted biotherapysignificantly increases the chances of achieving lasting remission (DAS28 <2.6).

  • icone - Choix de prescription

    To date, rheumatologists only have a few elements to help them choose what to prescribe.

RITI® identifies the biotherapy that is most suited to you, thereby optimising your therapeutic journey.

How does it work?

Chat with your doctor about it

Chat with your doctor about it

Your rheumatologist adviced you about the RITI® test

Billions of calculations

Billions of calculations

Our algorithms are performing billions of calculations to determine the most suitable biotherapy for you and create a customized report

Find out more
Your biotherapy is targeted

Your biotherapy is targeted

Your doctor receives your personalized report indicating which is the most efficient biotherapy. Talk to him about the best treatment options available to you.

Find out more

I would like to speak about it with my doctor

I would like to speak about it with my doctor

I would like to download the brochure

My rheumatologist adviced me about the RITI® test

My doctor told me about the Test.

I book my RITI®

They're talking about us in the news

Frequently asked questions

Is the RITI® test an option for me?

Icon plus

RITI® is an option for you as soon as your GP diagnoses your rheumatoid arthritis and makes his/her own decision to prescribe a biotherapy.

Two scenarios:

• First initial prescription from your doctor

  • you are a virgin of biotherapy

• You have already had biotherapy prescribed by your doctor BUT

  • no decrease in symptoms (primary failure)
  • a reduction in the symptoms felt then more effect with an increase in symptoms (secondary escape)
 

The innovative Test offered by mYXpression allows your doctor to have an additional element at his disposal to assist him in his therapeutic choice.

How is my data managed?

Icon plus

At mYXpression, we ensure the respect of your privacy and the security of your digital data in accordance with the RGDP regulations of May 25, 2018.

Talk to your rheumatologist

Icon plus

Your rheumatologist plays a key role in defining your therapeutic path.

In order to present RITI®, we kindly invite you to download the information brochure.

Do you have questions?Contact us.

OUR PARTNERS

Logo bfcare
Logo bpifrance
Logo initiative
Logo laureat
Logo village
Logo medicen
Logo JEI
Logo propulseur